JP2005029776A - Perfume composition - Google Patents
Perfume composition Download PDFInfo
- Publication number
- JP2005029776A JP2005029776A JP2004090937A JP2004090937A JP2005029776A JP 2005029776 A JP2005029776 A JP 2005029776A JP 2004090937 A JP2004090937 A JP 2004090937A JP 2004090937 A JP2004090937 A JP 2004090937A JP 2005029776 A JP2005029776 A JP 2005029776A
- Authority
- JP
- Japan
- Prior art keywords
- fragrance
- secretion
- seed oil
- fragrance composition
- amblet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- 239000002304 perfume Substances 0.000 title claims abstract description 10
- 229940088597 hormone Drugs 0.000 claims abstract description 31
- 239000005556 hormone Substances 0.000 claims abstract description 31
- 230000028327 secretion Effects 0.000 claims abstract description 22
- 238000002360 preparation method Methods 0.000 claims abstract description 11
- 235000013305 food Nutrition 0.000 claims abstract description 8
- ALHUZKCOMYUFRB-OAHLLOKOSA-N Muscone Chemical compound C[C@@H]1CCCCCCCCCCCCC(=O)C1 ALHUZKCOMYUFRB-OAHLLOKOSA-N 0.000 claims abstract description 6
- ALHUZKCOMYUFRB-UHFFFAOYSA-N muskone Natural products CC1CCCCCCCCCCCCC(=O)C1 ALHUZKCOMYUFRB-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000003205 fragrance Substances 0.000 claims description 64
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 17
- 241000402754 Erythranthe moschata Species 0.000 claims description 9
- 230000001737 promoting effect Effects 0.000 claims description 7
- 230000009245 menopause Effects 0.000 claims description 6
- 230000009759 skin aging Effects 0.000 claims description 2
- NVIPUOMWGQAOIT-UHFFFAOYSA-N (E)-7-Hexadecen-16-olide Natural products O=C1CCCCCC=CCCCCCCCCO1 NVIPUOMWGQAOIT-UHFFFAOYSA-N 0.000 abstract description 4
- NVIPUOMWGQAOIT-DUXPYHPUSA-N 7-hexadecen-1,16-olide Chemical compound O=C1CCCCC\C=C\CCCCCCCCO1 NVIPUOMWGQAOIT-DUXPYHPUSA-N 0.000 abstract description 4
- ZKVZSBSZTMPBQR-UHFFFAOYSA-N Civetone Natural products O=C1CCCCCCCC=CCCCCCCC1 ZKVZSBSZTMPBQR-UHFFFAOYSA-N 0.000 abstract description 3
- ZKVZSBSZTMPBQR-UPHRSURJSA-N civetone Chemical compound O=C1CCCCCCC\C=C/CCCCCCC1 ZKVZSBSZTMPBQR-UPHRSURJSA-N 0.000 abstract description 3
- 239000001262 hibiscus abelmoschus l. seed oil Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 description 27
- 239000000047 product Substances 0.000 description 23
- 230000000694 effects Effects 0.000 description 20
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 14
- 210000003491 skin Anatomy 0.000 description 14
- -1 Cyclopentadecanide Chemical compound 0.000 description 12
- 210000003296 saliva Anatomy 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- 239000000835 fiber Substances 0.000 description 11
- 229940011871 estrogen Drugs 0.000 description 10
- 239000000262 estrogen Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 229960005309 estradiol Drugs 0.000 description 8
- 235000019441 ethanol Nutrition 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 7
- 239000006185 dispersion Substances 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 239000003094 microcapsule Substances 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 239000004753 textile Substances 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000007937 lozenge Substances 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 229930182833 estradiol Natural products 0.000 description 3
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 3
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 3
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000000284 resting effect Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- GJJSUPSPZIZYPM-UHFFFAOYSA-N 1,4-dioxacyclohexadecane-5,16-dione Chemical compound O=C1CCCCCCCCCCC(=O)OCCO1 GJJSUPSPZIZYPM-UHFFFAOYSA-N 0.000 description 2
- MRMOPGVGWFNHIN-UHFFFAOYSA-N 1,6-dioxacycloheptadecan-7-one Chemical compound O=C1CCCCCCCCCCOCCCCO1 MRMOPGVGWFNHIN-UHFFFAOYSA-N 0.000 description 2
- LOKPJYNMYCVCRM-UHFFFAOYSA-N 16-Hexadecanolide Chemical compound O=C1CCCCCCCCCCCCCCCO1 LOKPJYNMYCVCRM-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- FKUPPRZPSYCDRS-UHFFFAOYSA-N Cyclopentadecanolide Chemical compound O=C1CCCCCCCCCCCCCCO1 FKUPPRZPSYCDRS-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000011162 core material Substances 0.000 description 2
- 239000002285 corn oil Substances 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 229940099112 cornstarch Drugs 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- OSOIQJGOYGSIMF-UHFFFAOYSA-N cyclopentadecanone Chemical compound O=C1CCCCCCCCCCCCCC1 OSOIQJGOYGSIMF-UHFFFAOYSA-N 0.000 description 2
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000002657 fibrous material Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000001256 steam distillation Methods 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 239000012209 synthetic fiber Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- XWNXEWLCHSLQOI-UHFFFAOYSA-K trisodium;triacetate Chemical compound [Na+].[Na+].[Na+].CC([O-])=O.CC([O-])=O.CC([O-])=O XWNXEWLCHSLQOI-UHFFFAOYSA-K 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- MKEIDVFLAWJKMY-UHFFFAOYSA-N 1,7-dioxacycloheptadecan-8-one Chemical compound O=C1CCCCCCCCCOCCCCCO1 MKEIDVFLAWJKMY-UHFFFAOYSA-N 0.000 description 1
- MZLRFHKWWCSGHB-UHFFFAOYSA-N 1,8-dioxacycloheptadecan-9-one Chemical compound O=C1CCCCCCCCOCCCCCCO1 MZLRFHKWWCSGHB-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- 241001075517 Abelmoschus Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000282375 Herpestidae Species 0.000 description 1
- 244000153234 Hibiscus abelmoschus Species 0.000 description 1
- 235000010616 Hibiscus abelmoschus Nutrition 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 241000219071 Malvaceae Species 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241001579678 Panthea coenobita Species 0.000 description 1
- 229920002845 Poly(methacrylic acid) Chemical class 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229920001807 Urea-formaldehyde Polymers 0.000 description 1
- 229920002978 Vinylon Polymers 0.000 description 1
- IJCWFDPJFXGQBN-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-octadecanoyloxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-RYNSOKOISA-N 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229920003235 aromatic polyamide Polymers 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- DAZYFPVYDAKNQJ-UHFFFAOYSA-N cyclohexadec-2-en-1-one Chemical compound O=C1CCCCCCCCCCCCCC=C1 DAZYFPVYDAKNQJ-UHFFFAOYSA-N 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000009207 exercise therapy Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- RZRNAYUHWVFMIP-HXUWFJFHSA-N glycerol monolinoleate Natural products CCCCCCCCC=CCCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-HXUWFJFHSA-N 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 229940125697 hormonal agent Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000012770 industrial material Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 150000002678 macrocyclic compounds Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940057917 medium chain triglycerides Drugs 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 238000001671 psychotherapy Methods 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 239000001589 sorbitan tristearate Substances 0.000 description 1
- 235000011078 sorbitan tristearate Nutrition 0.000 description 1
- 229960004129 sorbitan tristearate Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fats And Perfumes (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
本発明は女性ホルモンの分泌を促進させる香料組成物に関するものであり、更にその香料組成物を含有する皮膚外用剤、雑貨、食品などに関する。 The present invention relates to a fragrance composition that promotes secretion of female hormones, and further relates to an external preparation for skin, miscellaneous goods, food, and the like containing the fragrance composition.
一般的に女性のライフスタイルには、女性ホルモンの働きが密接に関係していることが従来の研究によって知られている(例えば特許文献1,非特許文献1,2参照)。女性ホルモンには、卵巣から分泌される卵胞ホルモン(エストロゲン)と黄体ホルモン(プロゲステロン)があり、これらが拮抗的あるいは相乗的に働いて女性ホルモンとしての作用を調節している。 In general, it has been known from conventional studies that female hormones are closely related to the action of female hormones (see, for example, Patent Document 1, Non-Patent Documents 1 and 2). Female hormones include follicular hormone (estrogen) and progesterone secreted from the ovary, and these act antagonistically or synergistically to control the action as female hormones.
更年期障害とは、閉経を中心としたその前後に、不定愁訴とよばれる他人には分からない不快感を伴うもので、女性ホルモンのバランスが乱れることによって起こると考えられている。具体的な症状としては、顔がほてる、のぼせる、頭がいたい、吐き気がする、腹が張る、体がむくむなどの身体的症状、イライラする、無気力になる、不安になる、憂うつになるなどの精神的症状、人に会いたくない、家に引きこもる、家族や友人へ暴言をはくなどの社会的症状があるが、女性にとってそれらの症状に対する悩みは深刻である。更年期障害の治療法としては、ホルモン剤の投与、精神安定剤の投与などがあるが、これらの治療はすべて副作用があり、治療として適切でない。その他、心理療法、運動療法、ストレスの解消などがあげられるが、あらゆる症状に対して有効な治療方法がないのが現状である。エストロゲンの分泌は更年期に急速に低下することが知られており、更年期障害のいくつかの症状はエストロゲンの低下が原因といわれていることから、女性ホルモンの分泌を促進することにより、これら更年期障害の改善が期待できる。 Menopause is mainly caused by menopause, which is accompanied by discomfort that is unknown to others, called indefinite complaints, and is thought to occur when the balance of female hormones is disturbed. Specific symptoms may include physical symptoms such as hot face, hotness, head ache, nausea, stomach upset, swollen body, irritation, lethargy, anxiety, and depression. There are social symptoms, such as psychological symptoms, not wanting to meet people, staying home, and ranting to family and friends, but women are seriously worried about these symptoms. Treatment methods for climacteric disorders include administration of hormonal agents and tranquilizers, but all of these treatments have side effects and are not suitable as treatments. Others include psychotherapy, exercise therapy, and stress relief, but there are currently no effective treatments for all symptoms. Estrogen secretion is known to decline rapidly during menopause, and some symptoms of climacteric disorder are said to be due to decreased estrogen. Improvement can be expected.
また、エストロゲンが皮膚に与える効果としては、以下のようなことが考えられる。まず、エストロゲンには皮膚の線維芽細胞に働きコラーゲンとヒアルロン酸の生合成を促進する作用がある。また、コラーゲンの合成は加齢に伴って低下し、架橋度の高いコラーゲンが増加することが知られているが、女性ホルモンには、コラーゲンの合成を促進し、生合成されて間もない若い低架橋コラーゲンの割合を増やす効果が認められている。このことは、真皮の若さを保ち皮膚に張りを与える効果につながる。次に、エストロゲンは、男性ホルモンと作用が拮抗することから、男性ホルモンで活性化される皮脂腺の機能亢進の低下作用がある。この効果はニキビなどの皮脂腺機能亢進症状に応用できる。さらに、エストロゲンには紫外線ストレスの軽減効果がある。同一線量の紫外線を雌雄のマウスに照射したとき、そのダメージは雄の方が大きく、雌の有するエストロゲンが紫外線に対して抵抗性を与えることが示唆されている(非特許文献3参照)。また、女性ホルモンの減少は、紫外線によるコラーゲン分解酵素の活性を高め、シワやタルミにつながっていくことから、女性ホルモンの分泌を促進することによりシワやタルミなどの皮膚の老化予防につながる(非特許文献4参照)。
以上のように、エストロゲンには、更年期障害、スキンケアの分野において有用な効果が期待できるが、ホルモンそのものを人体に投与または皮膚外用剤等により投与することは、安全性や規制の面から困難であると考えられる。すなわち、本発明は女性ホルモンの分泌を促進する香料組成物を提供することを課題とする。 As described above, estrogen can be expected to have a useful effect in the fields of menopause and skin care, but it is difficult to administer the hormone itself to the human body or by external skin preparations from the viewpoint of safety or regulation. It is believed that there is. That is, an object of the present invention is to provide a fragrance composition that promotes secretion of female hormones.
本発明者らは上記事項に鑑み、鋭意研究を重ねた結果、香料組成物であるアンブレット・シード油、大環状ムスクに優れた女性ホルモン分泌促進作用のあることを見出した。 In view of the above, the present inventors have conducted extensive research and found that the perfume composition, amblet seed oil and macrocyclic musk, have an excellent female hormone secretion promoting action.
アンブレット・シード油(Ambrette seed oil,concrete,absolute)
アンブレット・シード(種子)を産出する植物の一般名は、ニオイトロロアオイ、トロロアオイモドキと呼ばれる。この植物は熱帯アジア原産のアオイ科(Malvaceae)の一年草で、学名はAbelmoschus moschatus Moenchでオクラに似ているが果実は長さ8cm程の楕円形をしている。アンブレット・シード油と呼ばれるものには、アンブレット・シードコンクリート、アンブレット・シードアブソリュート、アンブレット・シードオイルがある。このうちアンブレット・シードコンクリートは、アンブレットの種子を揮発性溶剤で抽出し、その後溶剤を除去して得られるもので、このコンクリートをさらに水蒸気蒸留して得られるものが、アンブレット・シードアブソリュートである。通常天然香料の採取法において、アブソリュートは、コンクリートをアルコール抽出する方法で得られるが、この植物においては、アンブレット・シードコンクリートを水蒸気蒸留することにより得られるものがアンブレット・シードアブソリュートである。これは、コンクリート中に含まれる脂肪酸を除去するために行われる。また、アンブレット・シードオイルは、単にアンブレットの種子を水蒸気蒸留することによって得られるが、少量のパルミチン酸類が混入している。したがってこの精油は数ヶ月の熟成期間が必要で、熟成することにより脂肪酸臭が抑えられるという。香気は、豊かで甘く、フローラルムスキーでワイン様である。主香成分としてAmbrettolideを15%近く含有する(吉儀英記著,「香料入門」,フレグランスジャーナル社,p.213―215より)。
Amblet seed oil (concrete oil, concrete, absolute)
The common names of the plants that produce the amblet seeds are called scented oysters. This plant is an annual plant of Malvaceae native to tropical Asia. Its scientific name is Abelmoschus moschatus Moench, which resembles okra but has an oval shape with a length of about 8 cm. The so-called amblet seed oil includes amblet seed concrete, amblet seed absolute, and amblet seed oil. Ambret seed concrete is obtained by extracting the amblet seed with a volatile solvent and then removing the solvent. The concrete obtained by further steam distillation of this concrete is the Amblet Seed Absolute. It is. Usually, in the method of collecting natural fragrances, the absolute is obtained by a method of extracting concrete with alcohol, but in this plant, the one obtained by steam distillation of the ambret seed concrete is an ambret seed absolute. This is done to remove fatty acids contained in the concrete. Ambret seed oil is obtained by simply steam-distilling the seeds of amblet, but it contains a small amount of palmitic acid. Therefore, this essential oil requires a aging period of several months, and it is said that fatty acid odor is suppressed by aging. The aroma is rich and sweet, floral skiing and wine-like. Contains 15% Ambrettolide as the main scent component (from Hideki Yoshigi, “Introduction to Fragrances”, Fragrance Journal, p.213-215).
アンブレットリド(Ambrettolide)
豊かで、きわめてフローラルムスキー香が強く、甘い香りのやや粘着性の無色のオイル。フレグランスには有用な保留剤であり、アルコールに0.01%加えるだけで保留効果が確認できる。保留剤ではあるが、フレグランスを引き立たせる効果があるといわれる(吉儀英記著,「香料入門」,フレグランスジャーナル社,p.215より)。
Ambrettolide
A rich, extremely floral musky scent with a sweet, slightly sticky, colorless oil. It is a useful retention agent for fragrances, and the retention effect can be confirmed only by adding 0.01% to alcohol. Although it is a retention agent, it is said to have an effect of enhancing fragrance (from Hideki Yoshigi, “Introduction to Fragrance”, Fragrance Journal, p. 215).
ムスコン(Muscone)
天然じゃ香の主香成分で、0.5〜2.0%含有されている。優雅なムスク香の結晶であるが、一般市販品は粘性ある液体である。最も望ましいムスク香で、高級香料に用いられており、フレーバーにも少量用いられる(印籐元一著,「合成香料 化学と商品知識」,化学工業日報社,p.492―495より)。
Muscone
It is the main incense component of natural fragrance and is contained in an amount of 0.5 to 2.0%. Although it is an elegant musk crystal, the general commercial product is a viscous liquid. The most desirable musk fragrance, used in high-quality fragrances, and used in small amounts in flavors (from Motoichi Into, “Synthetic fragrance chemistry and product knowledge”, Chemical Industry Daily, p. 492-495).
シベトン(Civetone)
霊猫香(シベット)の香気の本体で2〜3%含有されている。天然品は二重結合に関してcis体であるが、市販の合成品はtrans体を主体とした異性体の混合体である。拡散性のあるアニマル、ムスク香の無色液体である(印籐元一著,「合成香料 化学と商品知識」,化学工業日報社,p.496より)。
Civetone
It is contained 2-3% in the main body of fragrance of ghost cat incense (civet). A natural product is a cis isomer with respect to a double bond, but a commercially available synthetic product is a mixture of isomers mainly composed of a trans isomer. It is a colorless liquid of diffusible animal and musk fragrance (from Motoichi Inushi, “Synthetic Fragrance Chemistry and Product Knowledge”, Chemical Industry Daily, p. 496).
本発明の大環状とは、構成炭素数が14〜17のものを指す。 The macrocycle of the present invention refers to those having 14 to 17 carbon atoms.
本発明の大環状ムスクとは、例えばムスコン(Muscone)、シベトン(Civetone)、シクロペンタデカノン(Cyclopentadecanone)、シクロヘキサデセノン(5−Cyclohexadecen−1−one)、シクロペンタデカノリド(Cyclopentadecanolide)、アンブレットリド(Ambrettolide)、シクロヘキサデカノリド(Cyclohexadecanolide)、10−オキサヘキサデカノリド(10−Oxahexadecanolide)、11−オキサヘキサデカノリド(11−Oxahexadecanolide)、12−オキサヘキサデカノリド(12−Oxahexadecanolide)、エチレンブラシレート(Ethylene brassylate)、エチレンドデカンジオエート(Ethylenedodecanedioate)などがあげられる。なかでも、アンブレットリド、ムスコン、シベトンが好ましい。 The macrocyclic musk of the present invention includes, for example, Muscone, Civetone, Cyclopentadecanone, Cyclohexadecenone (1-Cyclohexadecen-1-one), Cyclopentadecanolide, and Cyclopentadecanide. Ambrettolide, cyclohexadecanolide, 10-oxahexadecanolide, 11-oxahexadecanolide, 12-oxahexadecanolide, 12-oxahexadecanolide, 12-oxahexadecanolide 12-Oxahexadecanolide, Ethylene brush rate (Ethylene b) assylate), such as ethylene dodecanedioate (Ethylenedodecanedioate), and the like. Of these, amblet lid, muscone, and civeton are preferable.
本発明におけるこれら香料組成物の配合量は、選択する香料組成物の種類や他の配合成分との関係等により適宜選択されるものであり特に限定されるものではないが、香料賦香率の目安は次のとおりである(%は重量%を示す)。0.001重量%以下では女性ホルモンの分泌促進効果において十分な効果が得られない場合があり、最大値以上の香料組成物を配合することは、製剤の安定性等の問題により困難なことがある。
製品の種類 好ましい賦香率(%) より好ましい賦香率(%)
クリーム 0.001〜3.0 0.05〜1.0
ローション 0.001〜1.0 0.01〜0.3
ミルクローション 0.001〜2.0 0.02〜0.5
フォームパック 0.001〜1.0 0.03〜0.5
エアゾール 0.001〜30 0.01〜10
入浴剤 0.001〜20 0.1〜10
フレグランス 0.001〜100 0.1〜30
ルームフレグランス 0.001〜100 0.01〜20
インセンス 0.001〜50 0.05〜30
トローチ剤 0.001〜0.5 0.01〜0.1
繊維製品 0.001〜5.0 0.1〜1.0
The blending amount of these fragrance compositions in the present invention is appropriately selected depending on the type of the fragrance composition to be selected and the relationship with other blending components, and is not particularly limited. The standard is as follows (% indicates% by weight). If it is 0.001% by weight or less, there may be a case where a sufficient effect cannot be obtained in the secretion promotion effect of female hormones. is there.
Product type Preferred fragrance rate (%) More preferred fragrance rate (%)
Cream 0.001-3.0 0.05-1.0
Lotion 0.001-1.0 0.01-0.3
Milk lotion 0.001-2.0 0.02-0.5
Foam pack 0.001-1.0 0.03-0.5
Aerosol 0.001-30 0.01-10
Bath agent 0.001-20 0.1-10
Fragrance 0.001-100 0.1-30
Room fragrance 0.001-100 0.01-20
Incense 0.001-50 0.05-30
Lozenges 0.001-0.5 0.01-0.1
Textile products 0.001-5.0 0.1-1.0
本発明の香料組成物は例えば化粧料、医薬品、医薬部外品等の皮膚外用剤、インセンス、空間散布剤、繊維製品等の雑貨類、トローチ剤などの食品のいずれにも使用できるが、これら用途に限定されるものではない。皮膚外用剤としては、例えばクリーム、ローション、ミルクローション、エッセンス、パック、フォーム、パウダー、軟膏等の形態に用いることが好ましい。雑貨類としては、インセンス、ルームフレグランス、フォーム状フレグランス、繊維製品等の形態に用いることが好ましい。繊維製品としては、ズボン、スカートなどの衣類、パンツ、ブラジャー、シャツ、ソックス、ストッキング、ガードルなどの肌着類、水着、タオル、ハンカチ、マスク、手袋、布団、じゅうたん、カーテン、枕カバー、自動車内外装品、産業資材等があげられる。また、これら繊維製品の中でも、特に、直接肌に接する肌着類が、摩擦により香りを感じやすく、体温により香りが立ちやすい点で好ましい。食品としては、口に入ったときに香りを感じやすい形態であるトローチ剤、ドロップ剤等に用いることが好ましい。また、いくつかの使用方法を併用することも可能である。 The fragrance composition of the present invention can be used for any of foods such as cosmetics, pharmaceuticals, skin external preparations such as quasi-drugs, incense, space sprays, miscellaneous goods such as textiles, and lozenges, It is not limited to these uses. As an external preparation for skin, for example, it is preferably used in the form of cream, lotion, milk lotion, essence, pack, foam, powder, ointment and the like. As miscellaneous goods, it is preferable to use in forms such as incense, room fragrance, foam-like fragrance, and textile products. Textile products include clothes such as trousers, skirts, underwear such as pants, bras, shirts, socks, stockings, girdle, swimwear, towels, handkerchiefs, masks, gloves, duvets, carpets, curtains, pillowcases, interior and exterior of automobiles Products and industrial materials. Among these textile products, in particular, underwear that is in direct contact with the skin is preferable in that it is easy to feel a scent by friction and a scent is easily generated by body temperature. As food, it is preferable to use it for lozenges, drop agents, etc., which are in a form that makes it easy to feel the scent when entering the mouth. Moreover, it is also possible to use several usage methods in combination.
本発明における繊維製品の、繊維材料としては特に制限はなく、綿、絹、ウール等の天然繊維、レーヨン等の再生繊維、アセテート等の半合成繊維、ポリエステル、ナイロン、ポリエチレン、ポリプロピレン、ポリウレタン、ビニロン、ポリアラミド等又はそれらの混合物からなる合成繊維、ならびにこれらの繊維の複合繊維等が用いられ、その形態としては糸、編物、織物、不織布またはそれらの積層体等があげられる。 The fiber material of the fiber product in the present invention is not particularly limited, and natural fibers such as cotton, silk and wool, regenerated fibers such as rayon, semi-synthetic fibers such as acetate, polyester, nylon, polyethylene, polypropylene, polyurethane, and vinylon. , Synthetic fibers made of polyaramid or the like or a mixture thereof, and composite fibers of these fibers are used. Examples of the form include yarns, knitted fabrics, woven fabrics, nonwoven fabrics, and laminates thereof.
本発明における香料組成物を上記繊維製品に固着する方法は特に制限されず、例えば本発明における香料組成物をマイクロカプセル化し、水または有機溶剤中に溶解または分散後、スプレー法、パッド法、浸漬法、コーティング法、プリント法等により繊維材料に付着させ、その後乾燥することにより固着することができる。また、耐久性をより向上させるために必要に応じて架橋剤やバインダー等を併用してもよい。さらに、他の機能性を付与させる添加剤と併用してもよく、例えば、柔軟剤、帯電防止剤、抗菌防臭剤等の繊維加工剤を併用することにより、多種多用途の加工等も可能となる。 The method for fixing the fragrance composition in the present invention to the fiber product is not particularly limited. For example, the fragrance composition in the present invention is microencapsulated, dissolved or dispersed in water or an organic solvent, spray method, pad method, immersion. It can be fixed by attaching to a fiber material by a method, a coating method, a printing method or the like and then drying. Moreover, in order to improve durability more, you may use a crosslinking agent, a binder, etc. together as needed. Furthermore, it may be used in combination with other additives that impart functionality, for example, by using together with fiber processing agents such as softeners, antistatic agents, antibacterial deodorants, etc. Become.
かかる皮膚外用剤、雑貨、食品には、通常用いられる各種成分、例えばチョーク、タルク、カオリン、デンプン、ショ糖、コーンスターチ等の粉体、鉱油、植物油、シリコーン油等の油または油状物質、ゼラチン、寒天、メチルセルロース等の天然高分子物質、ポリアクリル系化合物、ポリメタクリル酸系化合物、メラミン樹脂、尿素樹脂等の合成高分子物質、ソルビタントリオレエート、ソルビタントリステアレート、グリセロールモノオレエート、高分子シリコーン界面活性剤等の乳化剤、メチルパラベン等の防腐剤、ブチルヒドロキシトルエン等の酸化防止剤、グリセロール、ソルビトール、ジブチルフタレート、ゼラチン、ポリエチレングリコール等の潤滑剤、トリエタノールアミンまたは水酸化ナトリウムのような塩基を伴う乳酸等の緩衝剤、グリセロールエーテルおよび合成、動物性または植物性セラミド等の界面活性剤、ミツロウ、オゾケライトワックス、パラフィン等のワックス類、増粘剤、活性増強剤、着色料等を必要に応じ適宜組み合わせて用いることができる。 For such external preparations for skin, sundries, foods, various commonly used ingredients such as powders such as chalk, talc, kaolin, starch, sucrose, corn starch, oils or oils such as mineral oil, vegetable oil, silicone oil, gelatin, Natural polymer materials such as agar and methyl cellulose, polyacrylic compounds, polymethacrylic acid compounds, synthetic polymer materials such as melamine resins and urea resins, sorbitan trioleate, sorbitan tristearate, glycerol monooleate, polymeric silicone Emulsifiers such as surfactants, preservatives such as methyl paraben, antioxidants such as butylhydroxytoluene, lubricants such as glycerol, sorbitol, dibutyl phthalate, gelatin, polyethylene glycol, bases such as triethanolamine or sodium hydroxide Accompanying lactic acid Buffers, glycerol ethers and surfactants such as synthetic, animal or vegetable ceramides, beeswax, ozokerite wax, waxes such as paraffin, thickeners, activity enhancers, coloring agents, etc. as necessary They can be used in combination.
上記女性ホルモンの分泌を促進させる香料組成物以外にも、本組成物が取りうる具体的な態様に応じて、一般的な香料成分を本発明の効果を損なわない限り配合することができる。 In addition to the fragrance composition that promotes the secretion of female hormones, general fragrance ingredients can be blended according to the specific modes that the present composition can take as long as the effects of the present invention are not impaired.
本発明の香料組成物はそれ自体で単独で使用することもでき、さらに他の女性ホルモンの分泌促進剤、例えば蒲公英根、当帰、香附子、牡丹皮、山薬などと併用することもできる。 The perfume composition of the present invention can be used by itself, and can also be used in combination with other female hormone secretion promoters, for example, Koei Ekine, Toki, Katsuki, Peony skin, Yamayaku, etc. .
本発明の香料組成物およびその香料組成物を含有する皮膚外用剤、雑貨、食品などは、女性ホルモン分泌促進効果に優れていた。 The fragrance composition of the present invention and the external preparation for skin, miscellaneous goods, food and the like containing the fragrance composition were excellent in the effect of promoting female hormone secretion.
以下、本発明にかかる女性ホルモンの分泌を促進する香料組成物を、製造例により詳細に説明する。なお、本発明はこれらに限定されるものではない。製造例において%は重量%を意味する。 Hereinafter, the perfume composition that promotes secretion of female hormones according to the present invention will be described in more detail with reference to production examples. The present invention is not limited to these. In the production examples, “%” means “% by weight”.
製造例1.クリーム
1.グリセリン 3%
2.ジプロピレングリコール 7%
3.ポリエチレングリコール 3%
4.ステアリン酸グリセリル 3%
5.ステアリルアルコール 2%
6.流動パラフィン 7%
7.シクロメチコン 3%
8.ジメチコン 1%
9.エチルパラベン 0.5%
10.エチレンジアミンヒドロキシエチル
三酢酸3ナトリウム 0.01%
11.精製水 残余
12.アンブレットリド(高砂香料工業株式会社製)
(香料) 0.1%
(製造方法)成分4〜9を加熱溶解して混合し、70℃に保ち油相とする。成分1〜3および成分10、11を加熱溶解して混合し、75℃に保ち水相とする。油相に水相を加えて乳化して、かき混ぜながら冷却し、45℃で成分12を加え、更に30℃まで冷却して製品とする。
Production Example 1 Cream 1. Glycerin 3%
2. Dipropylene glycol 7%
3. Polyethylene glycol 3%
4). Glyceryl stearate 3%
5. Stearyl alcohol 2%
6). Liquid paraffin 7%
7. Cyclomethicone 3%
8). Dimethicone 1%
9. Ethylparaben 0.5%
10. Ethylenediamine hydroxyethyl trisodium triacetate 0.01%
11. Purified water Residual 12. Ambret lid (manufactured by Takasago International Corporation)
(Fragrance) 0.1%
(Manufacturing method) Components 4 to 9 are dissolved by heating and mixed, and kept at 70 ° C to obtain an oil phase. Ingredients 1 to 3 and ingredients 10 and 11 are dissolved by heating and mixed, and kept at 75 ° C. to obtain an aqueous phase. The aqueous phase is added to the oil phase to emulsify, and the mixture is cooled while stirring. The component 12 is added at 45 ° C, and further cooled to 30 ° C to obtain a product.
製造例2.フレグランス
1.アルコール 75%
2.ジプロピレングリコール 1%
3.ムスコン(日本フィルメニッヒ株式会社製) 5%
4.調合香料(フローラルブーケ調) 15%
5.酸化防止剤 適量
6.紫外線吸収剤 適量
7.色素 適量
8.精製水 残余
(製造方法)成分1〜6と、成分7および8をそれぞれ均一に溶解し、両者を混合した後、ろ過を行い製品とする。
Production Example 2 Fragrance Alcohol 75%
2. Dipropylene glycol 1%
3. Muscon (Nippon Filmenich Co., Ltd.) 5%
4). Blended fragrance (floral bouquet tone) 15%
5. Antioxidant appropriate amount 6. 6. UV absorber appropriate amount Appropriate amount of dye 8. Purified water The remaining (manufacturing method) components 1 to 6 and components 7 and 8 are uniformly dissolved and mixed together, followed by filtration to obtain a product.
ここで「フレグランス」とは、アルコール(例えばエチルアルコール)または水性アルコールに本発明の香料組成物を溶解したものである。水とアルコールの配合比は、50:50から0:100の範囲である。フレグランスは、溶解剤、柔軟化剤、保湿剤、濃化剤、静菌剤、またはその他化粧品に通常用いられる材料を含有することができる。通常の調香手段を用いて、本発明の香料組成物に調和する香料成分を更に添加して変調し、保留性やこくなどを加えて仕上げたり、あるいはトップノート、ミドルノート、ラストノートを適当に組み合わせて経時的にも魅力的な芳香を発する配合物を調製することができる。 Here, the “fragrance” is obtained by dissolving the fragrance composition of the present invention in alcohol (for example, ethyl alcohol) or aqueous alcohol. The mixing ratio of water and alcohol is in the range of 50:50 to 0: 100. Fragrances can contain solubilizers, softeners, humectants, thickeners, bacteriostats, or other materials commonly used in cosmetics. Using normal scenting means, add fragrance ingredients that harmonize with the fragrance composition of the present invention to modulate and finish by adding retentivity and body, or suitable top note, middle note, last note In combination, it is possible to prepare a formulation that emits an attractive fragrance over time.
製造例3.練り香水
1.ジペンタエリトリット脂肪酸エステル 20%
2.マイクロクロスタリンワックス 20%
3.パラフィン 4%
4.アンブレット・シードオイル
(高砂香料工業株式会社製) 3%
5.調合香料(グリーン・フルーティ調) 5%
6.色素 適量
7.ワセリン 残余
(製造方法)成分1〜7を70℃で均一に溶解し、30℃まで冷却して製品とする。
Production Example 3 Kneaded perfume Dipentaerythritol fatty acid ester 20%
2. Micro crostalin wax 20%
3. 4% paraffin
4). Ambret seed oil (manufactured by Takasago International Corporation) 3%
5. Blended fragrance (green fruity tone) 5%
6). Appropriate amount of dye 7. Vaseline The remaining (manufacturing method) components 1 to 7 are uniformly dissolved at 70 ° C and cooled to 30 ° C to obtain a product.
製造例4.ルームフレグランス
1.アルコール 80%
2.酸化防止剤 5%
3.アンブレットリド(高砂香料工業株式会社製) 10%
4.調合香料(シトラス・フレッシュ調) 5%
5.紫外線吸収剤 適量
6.色素 適量
7.精製水 残余
(製造方法)成分1〜5と、成分6および7をそれぞれ均一に溶解し、両者を混合して製品とする。
Production Example 4 Room fragrance Alcohol 80%
2. Antioxidant 5%
3. Ambret lid (manufactured by Takasago International Corporation) 10%
4). Blended fragrance (Citrus / Fresh) 5%
5. 5. UV absorber appropriate amount Appropriate amount of dye 7. Purified water The remaining (manufacturing method) components 1 to 5 and components 6 and 7 are uniformly dissolved, and both are mixed to obtain a product.
製造例5.インセンス
1.タブ粉 75%
2.安息香酸ナトリウム 15%
3.シベトン(日本フィルメニッヒ株式会社製) 1%
4.調合香料(オリエンタル調) 15%
5.精製水 残余
(製造方法)成分1〜5を均一に混合し、練り機で練った後成型したものを乾燥させ製品とする。
Production Example 5 Insense Tab powder 75%
2. Sodium benzoate 15%
3. Sibeton (Nippon Filmenich Co., Ltd.) 1%
4). Blended fragrance (Oriental) 15%
5. Purified water The remaining (manufacturing method) components 1 to 5 are uniformly mixed, and after kneading with a kneader, the molded product is dried to obtain a product.
製造例6.ローション
1.グリセリン 3%
2.1,3−ブチレングリコール 3%
3.トリメチルグリシン 0.1%
4.メチルパラベン 0.2%
5.エチレンジアミン四酢酸3ナトリウム 0.02%
6.染料 適量
7.ムスコン(日本フィルメニッヒ株式会社製) 0.02%
8.POE(18)オレイルアルコールエーテル 0.5%
9.精製水 残余
(製造方法)成分1〜4と、成分5〜9をそれぞれ均一に溶解し、両者を混合しろ過して製品とする。
Production Example 6 Lotion 1. Glycerin 3%
2. 1,3-butylene glycol 3%
3. Trimethylglycine 0.1%
4). Methylparaben 0.2%
5. Ethylenediaminetetraacetic acid trisodium 0.02%
6). Appropriate amount of dye 7. Muscon (Nippon Filmenich Co., Ltd.) 0.02%
8). POE (18) oleyl alcohol ether 0.5%
9. Purified water Residue (manufacturing method) Components 1 to 4 and components 5 to 9 are uniformly dissolved, and both are mixed and filtered to obtain a product.
製造例7.ミルクローション
1.ステアリン酸 2%
2.セチルアルコール 0.5%
3.ミツロウ 2%
4.POE(10)モノオレイン酸エステル 1%
5.メトキシケイ皮酸オクチル 2%
6.トリエタノールアミン 0.8%
7.グリセリン 7%
8.1,3−ブチレングリコール 0.5%
9.エチルパラベン 0.3%
10.エチレンジアミンヒドロキシエチル
三酢酸3ナトリウム 0.01%
11.アンブレット・シードオイル
(高砂香料工業株式会社製) 0.05%
12.精製水 残余
(製造方法)成分1〜7を加熱溶解して混合し、70℃に保ち油相とする。成分8〜10および成分12を加熱溶解して混合し、75℃に保ち水相とする。油相に水相を加えて乳化して、かき混ぜながら冷却し、45℃で成分11を加え、更に30℃まで冷却して製品とする。
Production Example 7 Milk lotion Stearic acid 2%
2. Cetyl alcohol 0.5%
3. Beeswax 2%
4). POE (10) monooleate 1%
5. Octyl methoxycinnamate 2%
6). Triethanolamine 0.8%
7. Glycerin 7%
8.1,3-butylene glycol 0.5%
9. Ethylparaben 0.3%
10. Ethylenediamine hydroxyethyl trisodium triacetate 0.01%
11. Ambret seed oil (manufactured by Takasago International Corporation) 0.05%
12 Purified water The remaining (manufacturing method) components 1 to 7 are heated and dissolved and mixed, and kept at 70 ° C. to obtain an oil phase. Ingredients 8 to 10 and ingredient 12 are dissolved by heating and mixed, and kept at 75 ° C. to obtain an aqueous phase. The aqueous phase is added to the oil phase to emulsify, and the mixture is cooled while stirring. The component 11 is added at 45 ° C, and further cooled to 30 ° C to obtain a product.
製造例8.粉末入浴剤
1.炭酸水素ナトリウム 48%
2.アンブレットリド(高砂香料工業株式会社製) 3%
3.硫酸ナトリウム 残余
(製造方法)成分1〜3を均一に混合し製品とする。
Production Example 8 Powder bathing agent Sodium bicarbonate 48%
2. Ambret lid (manufactured by Takasago International Corporation) 3%
3. Sodium sulfate The remaining (manufacturing method) components 1 to 3 are uniformly mixed to obtain a product.
製造例9.液体入浴剤
1.テトラオレイン酸POE(30)ソルビトール 14%
2.セスキオレイン酸ソルビタン 3%
3.スクワラン 10%
4.ホホバ油 20%
5.エチルパラベン 0.1%
6.流動パラフィン 残余
7.POE(2)オレイルエーテル 3%
8.シベトン(日本フィルメニッヒ株式会社製) 2%
(製造方法)成分1〜6を60℃で均一に溶解し、成分7および8を均一に溶解したものと混合して製品とする。
Production Example 9 Liquid bath 1. Tetraoleic acid POE (30) Sorbitol 14%
2. Sorbitan sesquioleate 3%
3. Squalane 10%
4). Jojoba oil 20%
5. Ethylparaben 0.1%
6). Liquid paraffin residue 7. POE (2) oleyl ether 3%
8). Sibeton (Nippon Filmenich Co., Ltd.) 2%
(Manufacturing method) Components 1-6 are uniformly dissolved at 60 ° C., and components 7 and 8 are uniformly dissolved to obtain a product.
製造例10.トローチ剤
1.粉糖 60%
2.コーンスターチ 残余
3.ショ糖脂肪酸エステル 3.0%
4.ムスコン(日本フィルメニッヒ株式会社製) 0.002%
5.メントール 0.01%
(製造方法)成分1および2を流動層造粒機にて造粒後、成分3〜5を添加し、打錠機により成型して製品とする。
Production Example 10 Lozenges 60% powdered sugar
2. Cornstarch residue Sucrose fatty acid ester 3.0%
4). Muscon (Nippon Filmenich Co., Ltd.) 0.002%
5. Menthol 0.01%
(Manufacturing method) Components 1 and 2 are granulated with a fluid bed granulator, then components 3 to 5 are added, and molded with a tableting machine to obtain a product.
製造例11.ストッキング
(製造方法)アンブレット・シードオイル(高砂香料工業株式会社製)と中鎖トリグリセリドとを重量比が1/1となるように混合、溶解したこのマイクロカプセル芯物質50重量部にメタクリル酸メチル10重量部および過酸化ベンゾイル0.02重量部を溶解させた後、ラウリル硫酸ナトリウム1重量%水溶液100重量部に70℃で分散させてプロペラ撹拌によって芯物質の粒径コントロールを行ったマイクロカプセル調整用分散液を得た。この分散液を窒素を導入しながら70℃で4時間重合を行い、in−situ重合法によりマイクロカプセル化を行って、マイクロカプセル分散液を得た。この分散液を洗浄、ろ過乾燥して繊維処理用マイクロカプセルを調整した。この繊維処理用マイクロカプセル10重量部をバインダーとなるエポキシ変性ジメチルシロキサン水性エマルション30重量部に分散させて繊維処理用マイクロカプセル分散液を調整し、この分散液にストッキングを浸漬、乾燥させてマイクロカプセルを固着させ、マイクロカプセル固着繊維(ストッキング)を得た。
Production Example 11 Stockings (manufacturing method) Ambret seed oil (manufactured by Takasago International Corporation) and medium chain triglycerides mixed and dissolved in a weight ratio of 1/1 to 50 parts by weight of this microcapsule core substance with methyl methacrylate 10 parts by weight and 0.02 parts by weight of benzoyl peroxide were dissolved, and then dispersed in 100 parts by weight of a 1% by weight aqueous solution of sodium lauryl sulfate at 70 ° C., and the particle size of the core material was controlled by propeller stirring. A dispersion was obtained. The dispersion was polymerized at 70 ° C. for 4 hours while introducing nitrogen, and microencapsulated by an in-situ polymerization method to obtain a microcapsule dispersion. The dispersion was washed, filtered and dried to prepare a microcapsule for fiber treatment. 10 parts by weight of the fiber processing microcapsules are dispersed in 30 parts by weight of an epoxy-modified dimethylsiloxane aqueous emulsion serving as a binder to prepare a fiber processing microcapsule dispersion. The stockings are immersed in the dispersion and dried to obtain microcapsules. Were fixed to obtain a microcapsule-fixed fiber (stockings).
本発明の効果を、以下の実験により説明する。
実験例1.本発明の香料組成物における女性ホルモンの分泌促進効果
代表的エストロゲンである、17β−エストラジオールの唾液中の量を測定した。6名の被験者に、それぞれアンブレット・シードオイル、アンブレットリド、ムスコン、シベトンの香りを嗅がせ、香りを嗅ぐ前と、8分間香りを嗅がせその後10分間安静状態を保った後の、唾液中の17β−エストラジオールの濃度を比較した。
The effect of the present invention will be described by the following experiment.
Experimental Example 1 The secretion promotion effect of female hormones in the fragrance composition of the present invention The amount of 17β-estradiol, which is a typical estrogen, in saliva was measured. Saliva after scenting 6 subjects with scent of Ambret Seed Oil, Amblet Lido, Muscon, and Sibeton, before scenting, and after scenting for 8 minutes and then resting for 10 minutes The concentration of 17β-estradiol in was compared.
被験者を椅子に着席させ、安静状態を保った後唾液を採取し、香りの提示前のサンプルとした。安静状態を保ったままの被験者に、8分間香りをしみこませた紙を嗅がせ、その10分後に再び唾液を採取した。唾液は、滅菌したコットンを口に含んで1分間咀嚼させ、コットンに含まれた唾液をシリンジで搾り取ったあと、遠心分離をして、その上清を測定用唾液とした。唾液中の17β−エストラジオールは、17β−Estradiol(E2)ELISAキット(武田薬品工業株式会社)を用いて定量した。吸光値の測定にはマイクロプレートリーダー(モレキュラーデバイス社)を用いた。試料として、アンブレット・シードオイル(高砂香料工業株式会社)、アンブレットリド(高砂香料工業株式会社)、ムスコン(日本フィルメニッヒ株式会社)、シベトン(日本フィルメニッヒ株式会社)を用い、比較例として、ラベンダー油(ヴェ・マン・フィス香料株式会社)、レモン油(高砂香料工業株式会社)を用いた。 After the subject was seated on the chair and kept at rest, saliva was collected and used as a sample before presenting the scent. The subject who was in a resting state was sniffed with paper soaked with scent for 8 minutes, and saliva was collected again 10 minutes later. Saliva was sterilized with cotton in the mouth and chewed for 1 minute, and the saliva contained in the cotton was squeezed out with a syringe and then centrifuged, and the supernatant was used as measurement saliva. 17β-estradiol in saliva was quantified using a 17β-Estradiol (E2) ELISA kit (Takeda Pharmaceutical Co., Ltd.). A microplate reader (Molecular Device Co., Ltd.) was used for measuring the absorbance value. Ambret seed oil (Takasago International Corporation), Ambret Lido (Takasago International Corporation), Muscon (Nippon Filmmenich Co., Ltd.), Sibeton (Nippon Filmmenich Co., Ltd.) are used as samples, and Lavender is used as a comparative example. Oil (Ve Manfis Fragrance Co., Ltd.) and lemon oil (Takasago Fragrance Co., Ltd.) were used.
結果を表1に示す。表から明らかなように、香り提示前に比べて、アンブレット・シードオイル、アンブレットリド、ムスコン、シベトンの香りを嗅いだ後では、唾液中のエストラジオールの量が有意に増加しており、これらの香料の香りが女性ホルモンの分泌を促進することが明らかになった。 The results are shown in Table 1. As is clear from the table, the amount of estradiol in the saliva increased significantly after smelling the scent of Ambret Seed Oil, Amblet Lido, Muscone, and Civeton compared to before presenting the scent. It became clear that the scent of fragrances promoted the secretion of female hormones.
実験例2.本発明の香料組成物を配合した製剤における、女性ホルモンの分泌促進効果
製造例1の処方をベースに、香料の種類および配合量を変えてクリームを調製し、2gを手の甲に塗布して被験者に嗅がせた。それ以外は、実験例1と同様に行い、唾液中の17β−エストラジオールの量を測定した。結果を平均増加量として表2に示す。
Experimental Example 2. Based on the prescription of Production Hormone Secretion Production Example 1 in the preparation containing the fragrance composition of the present invention, a cream was prepared by changing the kind and amount of the fragrance, and 2 g was applied to the back of the hand to the subject. I smelled it. Other than that was carried out similarly to Experimental Example 1, and the amount of 17β-estradiol in saliva was measured. The results are shown in Table 2 as average increase.
表から明らかなように、本発明の香料を配合した製剤の香りを嗅いだ後では、唾液中のエストラジオールの量が増加しており、本発明の香料の香りが女性ホルモンの分泌を促進することが明らかになった。 As is apparent from the table, after smelling the scent of the preparation containing the fragrance of the present invention, the amount of estradiol in the saliva increases, and the fragrance of the fragrance of the present invention promotes the secretion of female hormones. Became clear.
実験例3.本発明の香料組成物を固着させた繊維製品における、女性ホルモンの分泌促進効果
製造例11のように香料を固着させたストッキングを用いて、実験例1と同様に実験を行った。ストッキングの着用前と、8分間香りつきのストッキングを着用後、10分間安静状態を保った後の、唾液中の17β−エストラジオールの濃度を比較した。結果を平均増加量として表3に示す。
Experimental Example 3. Experiments were carried out in the same manner as in Experimental Example 1 using stockings with a perfume adhered as in Production Example 11 of female hormone secretion promoting effect in a textile product to which the perfume composition of the present invention was affixed. The concentration of 17β-estradiol in the saliva was compared before wearing stockings and after wearing a scented stocking for 8 minutes and after resting for 10 minutes. The results are shown in Table 3 as average increases.
表から明らかなように、本発明の香料を固着したストッキングの着用後では、唾液中のエストラジオールの量が増加しており、本発明の香料の香りが女性ホルモンの分泌を促進することが明らかになった。 As is clear from the table, after wearing the stockings to which the fragrance of the present invention is fixed, the amount of estradiol in the saliva is increased, and it is clear that the fragrance of the fragrance of the present invention promotes the secretion of female hormones. became.
本発明の香料組成物およびその香料組成物を含有する皮膚外用剤、雑貨、食品などは、女性ホルモン分泌促進用として利用可能である。 The fragrance composition of the present invention and the external preparation for skin, miscellaneous goods, food and the like containing the fragrance composition can be used for promoting female hormone secretion.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004090937A JP4558363B2 (en) | 2003-06-19 | 2004-03-26 | Fragrance composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003174165 | 2003-06-19 | ||
JP2004090937A JP4558363B2 (en) | 2003-06-19 | 2004-03-26 | Fragrance composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005029776A true JP2005029776A (en) | 2005-02-03 |
JP4558363B2 JP4558363B2 (en) | 2010-10-06 |
Family
ID=34219995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004090937A Expired - Lifetime JP4558363B2 (en) | 2003-06-19 | 2004-03-26 | Fragrance composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4558363B2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006045103A (en) * | 2004-08-03 | 2006-02-16 | Kanebo Cosmetics Inc | Steroid hormone secretion regulator |
JP2008100981A (en) * | 2006-10-17 | 2008-05-01 | Engelhard Lyon Sas | USE OF SUBSTANCE FOR PROTECTING FGF-2 OR FGF-beta GROWTH FACTOR |
JP2011519353A (en) * | 2008-04-02 | 2011-07-07 | ビーエーエスエフ ビューティ ケア ソリューションズ フランス エスエーエス | Active ingredients that stimulate fibroblast proliferation and / or activity |
JP2012031199A (en) * | 2011-10-31 | 2012-02-16 | Kao Corp | Mitigator of premenstrual and/or intermenstrual, physical and/or mental unpleasantness |
JP2015193622A (en) * | 2014-03-28 | 2015-11-05 | 株式会社コーセー | Transparent oily cosmetic |
WO2017004282A1 (en) * | 2015-06-29 | 2017-01-05 | Takasago Internation Corporation (Usa) | Musk compositions and methods of use thereof |
US9925134B2 (en) | 2006-10-17 | 2018-03-27 | Basf Beauty Care Solutions France Sas | Use of substances to protect FGF-2 or FGF-beta growth factor |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63501954A (en) * | 1985-12-04 | 1988-08-04 | シエ−,デイ−ン | Transdermal administration of pharmaceuticals |
JPH0799946A (en) * | 1993-09-30 | 1995-04-18 | Keiko Nakamura | Health drink |
JPH10231496A (en) * | 1997-02-17 | 1998-09-02 | Nagaoka Jitsugyo Kk | Mint composition and its production |
JP2000154394A (en) * | 1998-11-18 | 2000-06-06 | Lion Corp | Perfume composition |
JP2001174450A (en) * | 1999-12-21 | 2001-06-29 | Shiseido Co Ltd | Method for evaluating fragrance and fragrance evaluation question sheet |
JP2001278763A (en) * | 2000-03-30 | 2001-10-10 | Kobayashi Pharmaceut Co Ltd | Cariostatic agent |
WO2001098442A1 (en) * | 2000-06-20 | 2001-12-27 | Shiseido Co., Ltd. | Stress-relieving perfumes and stress-relieving perfume compositions containing the same |
JP2002255850A (en) * | 2001-02-26 | 2002-09-11 | Shiseido Co Ltd | Skin aging inhibitor |
JP2003113019A (en) * | 2001-09-28 | 2003-04-18 | Lion Corp | Skin care preparation |
JP2005519096A (en) * | 2002-03-01 | 2005-06-30 | シーエスティー メディカル リミティド | Drugs for female sexual dysfunction |
-
2004
- 2004-03-26 JP JP2004090937A patent/JP4558363B2/en not_active Expired - Lifetime
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63501954A (en) * | 1985-12-04 | 1988-08-04 | シエ−,デイ−ン | Transdermal administration of pharmaceuticals |
JPH0799946A (en) * | 1993-09-30 | 1995-04-18 | Keiko Nakamura | Health drink |
JPH10231496A (en) * | 1997-02-17 | 1998-09-02 | Nagaoka Jitsugyo Kk | Mint composition and its production |
JP2000154394A (en) * | 1998-11-18 | 2000-06-06 | Lion Corp | Perfume composition |
JP2001174450A (en) * | 1999-12-21 | 2001-06-29 | Shiseido Co Ltd | Method for evaluating fragrance and fragrance evaluation question sheet |
JP2001278763A (en) * | 2000-03-30 | 2001-10-10 | Kobayashi Pharmaceut Co Ltd | Cariostatic agent |
WO2001098442A1 (en) * | 2000-06-20 | 2001-12-27 | Shiseido Co., Ltd. | Stress-relieving perfumes and stress-relieving perfume compositions containing the same |
JP2002255850A (en) * | 2001-02-26 | 2002-09-11 | Shiseido Co Ltd | Skin aging inhibitor |
JP2003113019A (en) * | 2001-09-28 | 2003-04-18 | Lion Corp | Skin care preparation |
JP2005519096A (en) * | 2002-03-01 | 2005-06-30 | シーエスティー メディカル リミティド | Drugs for female sexual dysfunction |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006045103A (en) * | 2004-08-03 | 2006-02-16 | Kanebo Cosmetics Inc | Steroid hormone secretion regulator |
JP4550514B2 (en) * | 2004-08-03 | 2010-09-22 | 花王株式会社 | Steroid hormone secretion regulator |
JP2008100981A (en) * | 2006-10-17 | 2008-05-01 | Engelhard Lyon Sas | USE OF SUBSTANCE FOR PROTECTING FGF-2 OR FGF-beta GROWTH FACTOR |
US9925134B2 (en) | 2006-10-17 | 2018-03-27 | Basf Beauty Care Solutions France Sas | Use of substances to protect FGF-2 or FGF-beta growth factor |
JP2011519353A (en) * | 2008-04-02 | 2011-07-07 | ビーエーエスエフ ビューティ ケア ソリューションズ フランス エスエーエス | Active ingredients that stimulate fibroblast proliferation and / or activity |
JP2012031199A (en) * | 2011-10-31 | 2012-02-16 | Kao Corp | Mitigator of premenstrual and/or intermenstrual, physical and/or mental unpleasantness |
JP2015193622A (en) * | 2014-03-28 | 2015-11-05 | 株式会社コーセー | Transparent oily cosmetic |
WO2017004282A1 (en) * | 2015-06-29 | 2017-01-05 | Takasago Internation Corporation (Usa) | Musk compositions and methods of use thereof |
WO2017004281A1 (en) * | 2015-06-29 | 2017-01-05 | Takasago International Corporation (Usa) | Musk composition and methods of use thereof |
CN107864620A (en) * | 2015-06-29 | 2018-03-30 | 高砂香料工业株式会社 | Moschus composition and its application method |
US10988706B2 (en) | 2015-06-29 | 2021-04-27 | Takasago International Corporation | Musk compositions and methods of use thereof |
US11820961B2 (en) | 2015-06-29 | 2023-11-21 | Takasago International Corporation | Musk compositions and methods of use thereof |
Also Published As
Publication number | Publication date |
---|---|
JP4558363B2 (en) | 2010-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2226063B1 (en) | High intensity fragrances | |
JP4889954B2 (en) | Fragrance composition for female hormone regulatory function adjustment | |
WO2002051428A1 (en) | Sympathetic-activating perfume composition | |
CN107148264A (en) | Intend Nannochloropsis oculata extract and its application | |
CN108366933A (en) | Active agent delivery system | |
JP5926199B2 (en) | Aging odor suppressant containing oolong tea extract and / or strawberry tea extract | |
JP2016074638A (en) | Pasty cleansing cosmetic | |
JP4805589B2 (en) | Estrogenic agent | |
JP2006347906A (en) | Moisture retention plant extract, and external preparation, cosmetic product, bathing agent and detergent containing the extract | |
JP2005029776A (en) | Perfume composition | |
KR20060008295A (en) | Composition for relieving unpleasant symptoms accompanying change in progesterone | |
JP2004217615A (en) | Cosmetic for improving psychological condition | |
JP5404985B2 (en) | Fragrance composition for male hormone adjustment | |
KR101981058B1 (en) | Fragrance composition having sound sleep effect | |
JP3951271B2 (en) | Body fat burning accelerator | |
JP4934242B2 (en) | Skin cosmetics | |
JP2006342070A (en) | Moisturizing plant extract, and external preparation, cosmetic, bathing agent and detergent each containing the extract | |
JP2011051970A (en) | Perfume composition for use in sleep improvement, and cosmetic containing the same, and method for improving sleep | |
JP2007031347A (en) | Composition for psychosedation | |
JP4626743B2 (en) | Skin conditioning composition and method for promoting percutaneous absorption of hair restorer | |
JP5478679B2 (en) | Fragrance composition and scented product for enhancing convenience | |
JP2012012385A (en) | Sympathetic nerve activator, and cosmetic, food and sundries containing the same | |
JP2012229300A (en) | Powdered aroma product, its production method, and its use method | |
JP5331319B2 (en) | Blood flow enhancement inhibitor and bath composition containing the blood flow enhancement inhibitor | |
JP4632895B2 (en) | Sleep improvement composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20041118 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070124 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100309 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100428 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100720 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100721 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4558363 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130730 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |